| Q37718532 | 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future. |
| Q45295503 | A primate model of Huntington's disease: cross-species implantation of striatal precursor cells to the excitotoxically lesioned baboon caudate-putamen |
| Q48423326 | Afferent and efferent connections of striatal grafts implanted into the ibotenic acid lesioned neostriatum in adult rats. |
| Q45294736 | Apomorphine-induced dyskinesias after excitotoxic caudate-putamen lesions and the effects of neural transplantation in non-human primates |
| Q68167514 | Cellular reaggregation in vivo: modular patterns in intrastriatal grafts derived from fetal striatal primordia |
| Q40457662 | Cholinergic neurotransmission studied in vivo using positron emission tomography or single photon emission computerized tomography |
| Q34547466 | Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease. |
| Q36847262 | Death in the substantia nigra: a motor tragedy |
| Q36016932 | Development of novel therapies for Huntington's disease: hope and challenge |
| Q37282964 | Differential regulation of neuropeptide mRNA expression in intrastriatal striatal transplants by host dopaminergic afferents |
| Q37311202 | Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease |
| Q34608910 | Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient |
| Q46190328 | Disappearance of GAD-mRNA and tyrosine hydroxylase in substantia nigra following striatal ibotenic acid lesions: Evidence for transneuronal regression |
| Q48810893 | Dopaminergic innervation of striatal grafts placed into different sites of normal striatum: differences in the tyrosine hydroxylase immunoreactive growth pattern |
| Q48640913 | Efferent Projections to the Host Brain from Intrastriatal Striatal Mouse-to-rat Grafts: Time Course and Tissue-type Specificity as Revealed by a Mouse Specific Neuronal Marker |
| Q54187931 | Embryonic striatal grafts reverse the disinhibitory effects of ibotenic acid lesions of the ventral striatum. |
| Q69650041 | Enhanced host perforant path innervation of neonatal dentate tissue after grafting to axon sparing, ibotenic acid lesions in adult rats |
| Q48154481 | Fetal cortical cell suspension grafts to the excitotoxically lesioned neocortex: anatomical and neurochemical studies of trophic interactions. |
| Q30441747 | Fetal neostriatal transplants in the rat: A light and electron microscopic Golgi study |
| Q48565035 | GABA(A) receptor subunit expression in intrastriatal striatal grafts comparison between normal developing striatum and developing striatal grafts. |
| Q36820627 | GABAergic circuits in the basal ganglia and movement disorders |
| Q43851080 | Gender differences in spontaneous and MK-801-induced activity after striatal lesions |
| Q33265987 | Generation of human cortical neurons from a new immortal fetal neural stem cell line. |
| Q41087697 | Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease |
| Q35601129 | Graft-induced behavioral recovery in an animal model of Huntington disease |
| Q44705837 | Grafting of fetal CA3 neurons to excitotoxic, axon-sparing lesions of the hippocampal CA3 area in adult rats. |
| Q36822322 | Huntington's disease: pathological mechanisms and therapeutic strategies |
| Q35374311 | Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. |
| Q37600345 | Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease |
| Q38347060 | Localization of dopamine receptors and associated mRNA in transplants of human fetal striatal tissue in rodents with experimental Huntington's disease |
| Q70068537 | Localization of immunoreactive GABA and enkephalin and NADPH-diaphorase-positive neurons in fetal striatal grafts in the quinolinic-acid-lesioned rat neostriatum |
| Q60620615 | Neural grafting to ischemic lesions of the adult rat hippocampus |
| Q48456926 | Neural transplantation in primates: towards brain repair in humans |
| Q43417471 | Physiological and morphological characterization of striatal neurons transplanted into the striatum of adult rats |
| Q42496794 | Progressive reparative gliosis in aged hosts and interferences with neural grafts in an animal model of Huntington's disease |
| Q59575365 | Release of acetylcholine and its dopaminergic control in slices from striatal grafts in the ibotenic acid-lesioned rat striatum |
| Q24794457 | Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease |
| Q31095565 | Sites of [3H]taurine Uptake in the Rat Substantia Nigra in Relation to the Release of Taurine from the Striatonigral Pathway |
| Q48238929 | Striatal neural transplants in the ibotenic acid-lesioned rat neostriatum. Cellular and functional aspects |
| Q44776704 | Striatal neurons in striatal grafts are derived from both post-mitotic cells and dividing progenitors |
| Q48336600 | Striatal transplants prevent AF64A-induced retention deficits |
| Q48715549 | The age of striatum determines the pattern and extent of dopaminergic innervation: a nigrostriatal double graft study |
| Q33790829 | Therapeutic Strategies in Huntington's Disease |
| Q35579484 | Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology |
| Q48257326 | Ultrastructural and immunohistochemical analysis of fetal mediobasal hypothalamic tissue transplanted into the aged rat brain |
| Q34695123 | Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease |